Stephen A. Hurly

Insider Reports History

Location
C/O Eleven Biotherapeutics, 215 First St. #400, Cambridge, MA
Signature
/s/ Amy Garabedian, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen A. Hurly:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LAVA Therapeutics NV Chief Executive Officer, Director Common Shares 0 $0 $1.63 Nov 13, 2025 Direct
LAVA Therapeutics NV Chief Executive Officer, Director Share Options (Right to Buy) 0 Nov 13, 2025 Direct

Insider Reports Filed by Stephen A. Hurly

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LVTX LAVA Therapeutics NV Nov 13, 2025 2 $0 4 Nov 17, 2025 Chief Executive Officer, Director
LVTX LAVA Therapeutics NV Feb 13, 2025 1 $0 4 Feb 18, 2025 Chief Executive Officer, Director
LVTX LAVA Therapeutics NV Jan 1, 2025 0 $0 3 Jan 2, 2025 Chief Executive Officer, Director